HCV GT4
Showing 26 - 50 of 4,415
Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-450/r/ABT-267, ABT-333,
Completed
- Hepatitis C Virus Infection
- +3 more
- ABT-450/r/ABT-267
- +2 more
- (no location specified)
Jul 8, 2021
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (procedure, drug, other)
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2022
Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (procedure, drug, biological)
Recruiting
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Chronic HCV Infection Trial in China (HEC74647PA+HEC110114, Placebo)
Recruiting
- Chronic HCV Infection
- HEC74647PA+HEC110114
- Placebo
-
Bengbu, Anhui, China
- +35 more
May 24, 2022
Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Recruiting
- Acute Bilineal Leukemia
- +8 more
- Azacitidine
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jan 24, 2023
Thyroid Function After Cardiopulmonary Resuscitation
Recruiting
- Heart Arrest
- +3 more
- TSH determination
- +4 more
-
Bochum, NRW, GermanyMedizinische Klinik I, Universitätsklinikum Bergmannsheil, Ruhr-
Aug 13, 2021
Aortic Valve Disease, Aortic Valve Disorder Trial in Worldwide (Trifecta GT (Glide Technology) Valve)
Active, not recruiting
- Aortic Valve Disease
- Aortic Valve Disorder
- Trifecta GT (Glide Technology) Valve
-
Rochester, Minnesota
- +26 more
Mar 10, 2022
Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)
Active, not recruiting
- Plasma Cell Leukemia
- +3 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2022
Kidney Failure, Hepatitis C, Kidney Disease, Chronic Trial in Boston (Glecaprevir and Pibrentasvir)
Recruiting
- Kidney Failure
- +2 more
- Glecaprevir and Pibrentasvir
-
Boston, MassachusettsMassachusetts General Hospital
Jun 4, 2021
Hematologic and Lymphocytic Disorder Trial in Houston (Allogeneic Hematopoietic Stem Cell Transplantation, Busulfan,
Recruiting
- Hematologic and Lymphocytic Disorder
- Allogeneic Hematopoietic Stem Cell Transplantation
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Aug 1, 2022
Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))
Completed
- Chronic Hepatitis C Virus (HCV) Infection Genotype 1
- ABT-450/r/ABT-267
- +2 more
-
Phoenix, Arizona
- +47 more
Jun 27, 2022
Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/pibrentasvir adult formulation, Glecaprevir/pibrentasvir pediatric
Completed
- Hepatitis C Virus (HCV)
- Glecaprevir/pibrentasvir adult formulation
- Glecaprevir/pibrentasvir pediatric formulation
-
San Francisco, California
- +37 more
Sep 19, 2022
Obesity Trial in Worldwide (Side-to-side anastomosis duodeno-ileostomy diversion procedure)
Recruiting
- Obesity
- Side-to-side anastomosis duodeno-ileostomy diversion procedure
-
Brussels, Belgium
- +4 more
Apr 4, 2022
Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, other, radiation)
Active, not recruiting
- Primary Myelofibrosis
- Secondary Myelofibrosis
- Allogeneic Hematopoietic Stem Cell Transplantation
- +11 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 10, 2023
HCV Infection Trial in Hong Kong (SOF+DCV+CDI-31244, SOF+DCV+CDI-31244+ASV)
Withdrawn
- HCV Infection
-
Hong Kong, Hong Kong SAR, Hong KongHumanity & Health Research Centre
May 5, 2020
Hepatitis C, Chronic Trial in Taiwan (P1101 + Ribavirin)
Recruiting
- Hepatitis C, Chronic
- P1101 + Ribavirin
-
Chiayi City, Taiwan
- +7 more
Jun 30, 2022
Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in
Active, not recruiting
- Hematopoietic Cell Transplantation Recipient
- +3 more
- Allogeneic Bone Marrow Transplantation
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
A Study of Chronic Hepatitis C Patients Treated With SOF/VEL/VOX
Recruiting
- Hepatitis C
-
Istanbul, TurkeyCerrahpasa Medical Faculty
Aug 26, 2023
Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, radiation)
Recruiting
- Primary Myelofibrosis
- Secondary Myelofibrosis
- Allogeneic Hematopoietic Stem Cell Transplantation
- +9 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 21, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia
Completed
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +14 more
- Aldesleukin
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Jul 31, 2022
Compensated Cirrhosis Trial in Bangkok (Grazaoprevir/Elbasavir, Grazaoprevir/Elbasavir/RBV)
Unknown status
- Compensated Cirrhosis
-
Bangkok, Thailand
- +1 more
Feb 11, 2020
Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir (GLE/PIB))
Recruiting
- Hepatitis C Virus (HCV)
- Glecaprevir/Pibrentasvir (GLE/PIB)
-
Chandler, Arizona
- +62 more
Aug 8, 2022
Recurrent DLBCL, Recurrent T-Cell Non-Hodgkin Lymphoma, Refractory DLBCL Trial in Houston (drug, procedure, other, biological)
Recruiting
- Recurrent Diffuse Large B-Cell Lymphoma
- +4 more
- Busulfan
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, OBV/PTV/r)
Completed
- Chronic Hepatitis C Virus
- Hepatitis C Virus
- (no location specified)
Jul 14, 2021
Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir)
Completed
- Hepatitis C Virus (HCV)
-
San Diego, California
- +24 more
Jul 14, 2021